Evidence map›Paper›PMID 33937049›Full record

ReviewFrontiers in oncology2021

Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors.

Kaibo Guo, Yuqian Feng, Xueer Zheng, Leitao Sun, Harpreet S Wasan, Shanming Ruan, Minhe Shen

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Kaibo GuoThe First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
Yuqian FengThe First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
Xueer ZhengThe First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
Leitao SunThe First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
Harpreet S WasanDepartment of Cancer Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Shanming RuanThe First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
Minhe ShenThe First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
Zhejiang Chinese Medical University · CNImperial College Healthcare NHS Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epithelial-to-mesenchymal transition (EMT), a complicated program through which polarized epithelial cells acquire motile mesothelial traits, is regulated by tumor microenvironment. EMT is involved in tumor progression, invasion and metastasis

Indexed as

cancer cell stemnesschemoresistanceepithelial-to-mesenchymal transitionmetastasisresveratrol

Identifiers

PMID33937049
PMCPMC8085503
OpenAlexW3153642037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.